These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33407782)

  • 1. An exercise trial for adults undergoing neoadjuvant chemoradiotherapy for rectal cancer proves not feasible: recommendations for future trials.
    Brunet J; Price J; Delluc C
    Trials; 2021 Jan; 22(1):26. PubMed ID: 33407782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
    Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial.
    Moug SJ; Mutrie N; Barry SJE; Mackay G; Steele RJC; Boachie C; Buchan C; Anderson AS
    Colorectal Dis; 2019 May; 21(5):548-562. PubMed ID: 30657249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
    Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.
    Loughney L; West MA; Kemp GJ; Rossiter HB; Burke SM; Cox T; Barben CP; Mythen MG; Calverley P; Palmer DH; Grocott MP; Jack S
    Trials; 2016 Jan; 17():24. PubMed ID: 26762365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
    Conroy T; Bosset JF; Etienne PL; Rio E; François É; Mesgouez-Nebout N; Vendrely V; Artignan X; Bouché O; Gargot D; Boige V; Bonichon-Lamichhane N; Louvet C; Morand C; de la Fouchardière C; Lamfichekh N; Juzyna B; Jouffroy-Zeller C; Rullier E; Marchal F; Gourgou S; Castan F; Borg C;
    Lancet Oncol; 2021 May; 22(5):702-715. PubMed ID: 33862000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
    Ganz PA; Hays RD; Spritzer KL; Rogatko A; Ko CY; Colangelo LH; Arora A; Hopkins JO; Evans TL; Yothers G
    Cancer; 2022 Sep; 128(17):3233-3242. PubMed ID: 35749631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
    Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
    Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients.
    Singh F; Galvão DA; Newton RU; Spry NA; Baker MK; Taaffe DR
    Integr Cancer Ther; 2018 Sep; 17(3):952-959. PubMed ID: 29888608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity aerobic interval training and resistance training are feasible in rectal cancer patients undergoing chemoradiotherapy: a feasibility randomized controlled study.
    Piraux E; Reychler G; Vancraeynest D; Geets X; Léonard D; Caty G
    Rep Pract Oncol Radiother; 2022; 27(2):198-208. PubMed ID: 36299392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
    Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
    Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
    Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study.
    Alejo LB; Pagola-Aldazabal I; Fiuza-Luces C; Huerga D; de Torres MV; Verdugo AS; Ortega Solano MJ; Felipe JL; Lucia A; Ruiz-Casado A
    J Cancer Res Ther; 2019; 15(1):20-25. PubMed ID: 30880749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Joseph K; Nijjar T; Fairchild A; Courneya KS
    Clin Colorectal Cancer; 2021 Sep; 20(3):216-226. PubMed ID: 34158253
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.